FDA Adverse Event Death Summary report: N

ZEPHYR ENDOBRONCHIAL VALVE (EBV)

MDR report key: 11988014 · Received June 11, 2021

Report

Report Number
3007797756-2021-00125
Event Type
Death
Date Received
June 11, 2021
Date of Event
May 12, 2021
Report Date
June 11, 2021
Manufacturer
PULMONX CORPORATION
Product Code
NJK
UDI-DI
00811907030126
PMA / PMN Number
P180002
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
003

Narratives

Description of Event or Problem · 1

THE FEMALE PATIENT, AGED (B)(6) YEARS OLD, WITH A DIAGNOSIS OF COPD/EMPHYSEMA AND A BASELINE HISTORY OF HYPERTENSION, ULCERATIVE COLITIS, AND FIBROMYALGIA HAD BEEN PREVIOUSLY TREATED FOR HER EMPHYSEMA WITH PLACEMENT OF SPIRATION VALVES IN THE LEFT UPPER LOBE (LUL). THE PATIENT UNDERWENT A BRONCHOSCOPY PROCEDURE ON (B)(6) 2021 WHERE THE EXISTING SPIRATION VALVES (PLACED 12 MONTHS AGO) WERE REMOVED (FOR LACK OF EFFECT) FROM THE LUL. SINCE THERE WAS ALSO A TARGET ON THE RIGHT SIDE OF THE LUNG (LITTLE TO NO COLLATERAL VENTILATION) 5 ZEPHYR VALVES WERE PLACED IN THE RIGHT UPPER AND RIGHT MIDDLE LOBE. THE PROCEDURE WAS UNEVENTFUL. THREE DAYS POST-PROCEDURE ((B)(6) 2021), THE PATIENT DEVELOPED PNEUMONIA IN THE LEFT LUNG. THE PNEUMONIA WAS TREATED WITH ANTIBIOTICS AND NEBULIZER THERAPY. THE PATIENT HAD INCREASED OXYGEN NEED AND WAS TRANSFERRED TO THE ICU WHERE THE PATIENT DEVELOPED TAKOTSUBO CARDIOMYOPATHY. THE PATIENT DID NOT RECOVER AND DIED ON (B)(6) 2021. NO AUTOPSY WAS PERFORMED. THE TREATING PHYSICIAN STATED THAT THE PNEUMONIA WAS IN THE LEFT LUNG AND LIKELY NOT RELATED TO THE ZEPHYR VALVES THAT WERE PLACED IN THE RIGHT UPPER AND RIGHT MIDDLE LOBES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
878470 ZEPHYR ENDOBRONCHIAL VALVE (EBV) ENDOBRONCHIAL VALVE NJK PULMONX CORPORATION ZEPHYR 4.0 EBV 504809-V7.0 00811907030126

Patients

Seq Age Sex Outcome Treatment
1 71 YR Death| H| R